These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 8215967
1. Functional and magnetic resonance imaging correlates of callosal involvement in multiple sclerosis. Pelletier J, Habib M, Lyon-Caen O, Salamon G, Poncet M, Khalil R. Arch Neurol; 1993 Oct; 50(10):1077-82. PubMed ID: 8215967 [Abstract] [Full Text] [Related]
2. [Interhemispheric transfer in multiple sclerosis. Morphofunctional correlations]. Pelletier J, Habib M, Brouchon M, Poncet M, Lyon-Caen O, Salamon G, Khalil R. Rev Neurol (Paris); 1992 Oct; 148(11):672-9. PubMed ID: 1303556 [Abstract] [Full Text] [Related]
3. A longitudinal study of callosal atrophy and interhemispheric dysfunction in relapsing-remitting multiple sclerosis. Pelletier J, Suchet L, Witjas T, Habib M, Guttmann CR, Salamon G, Lyon-Caen O, Chérif AA. Arch Neurol; 2001 Jan; 58(1):105-11. PubMed ID: 11176943 [Abstract] [Full Text] [Related]
4. Corpus callosum damage and interhemispheric transfer of information following closed head injury in children. Benavidez DA, Fletcher JM, Hannay HJ, Bland ST, Caudle SE, Mendelsohn DB, Yeakley J, Brunder DG, Harward H, Song J, Perachio NA, Bruce D, Scheibel RS, Lilly MA, Verger-Maestre K, Levin HS. Cortex; 1999 Jun; 35(3):315-36. PubMed ID: 10440072 [Abstract] [Full Text] [Related]
5. Corpus callosum size correlates with asymmetric performance on a dichotic listening task in healthy aging but not in Alzheimer's disease. Gootjes L, Bouma A, Van Strien JW, Van Schijndel R, Barkhof F, Scheltens P. Neuropsychologia; 2006 Jun; 44(2):208-17. PubMed ID: 15955540 [Abstract] [Full Text] [Related]
6. Cerebral disconnection in multiple sclerosis. Relationship to atrophy of the corpus callosum. Rao SM, Bernardin L, Leo GJ, Ellington L, Ryan SB, Burg LS. Arch Neurol; 1989 Aug; 46(8):918-20. PubMed ID: 2757533 [Abstract] [Full Text] [Related]
7. Corpus callosum morphometry and dichotic listening performance: individual differences in functional interhemispheric inhibition? Clarke JM, Lufkin RB, Zaidel E. Neuropsychologia; 1993 Jun; 31(6):547-57. PubMed ID: 8341413 [Abstract] [Full Text] [Related]
11. Corpus callosum atrophy is a possible indicator of region- and cell type-specific neuronal degeneration in Alzheimer disease: a magnetic resonance imaging analysis. Hampel H, Teipel SJ, Alexander GE, Horwitz B, Teichberg D, Schapiro MB, Rapoport SI. Arch Neurol; 1998 Feb; 55(2):193-8. PubMed ID: 9482361 [Abstract] [Full Text] [Related]
12. Functional correlates of callosal atrophy in relapsing-remitting multiple sclerosis patients. A preliminary MRI study. Barkhof FJ, Elton M, Lindeboom J, Tas MW, Schmidt WF, Hommes OR, Polman CH, Kok A, Valk J. J Neurol; 1998 Mar; 245(3):153-8. PubMed ID: 9553845 [Abstract] [Full Text] [Related]
13. Anatomical-behavioral relationships: corpus callosum morphometry and hemispheric specialization. Clarke JM, Zaidel E. Behav Brain Res; 1994 Oct 20; 64(1-2):185-202. PubMed ID: 7840886 [Abstract] [Full Text] [Related]
14. MRI-Defined Corpus Callosal Atrophy in Multiple Sclerosis: A Comparison of Volumetric Measurements, Corpus Callosum Area and Index. Granberg T, Bergendal G, Shams S, Aspelin P, Kristoffersen-Wiberg M, Fredrikson S, Martola J. J Neuroimaging; 2015 Oct 20; 25(6):996-1001. PubMed ID: 25786805 [Abstract] [Full Text] [Related]
15. Anterior corpus callosum atrophy and verbal fluency in multiple sclerosis. Pozzilli C, Bastianello S, Padovani A, Passafiume D, Millefiorini E, Bozzao L, Fieschi C. Cortex; 1991 Sep 20; 27(3):441-5. PubMed ID: 1743039 [Abstract] [Full Text] [Related]
19. Alternate finger tapping test in patients with migraine. Scherer P, Bauer H, Baum K. Acta Neurol Scand; 1997 Dec 20; 96(6):392-6. PubMed ID: 9449478 [Abstract] [Full Text] [Related]
20. In vivo imaging of region and cell type specific neocortical neurodegeneration in Alzheimer's disease. Perspectives of MRI derived corpus callosum measurement for mapping disease progression and effects of therapy. Evidence from studies with MRI, EEG and PET. Hampel H, Teipel SJ, Alexander GE, Pogarell O, Rapoport SI, Möller HJ. J Neural Transm (Vienna); 2002 May 20; 109(5-6):837-55. PubMed ID: 12111472 [Abstract] [Full Text] [Related] Page: [Next] [New Search]